Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page
- Check2 days agoChange DetectedThe notice about government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedVersion 2 updates Study Status, Sponsor/Collaborators, and Contacts/Locations. Version 3 updates Recruitment Status, Study Status, Study Design, and Contacts/Locations.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates current operating status and references official sources.SummaryDifference13%

- Check52 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check66 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.8%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%

Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.